Thyroid Eye Disease

Lasting quality of life improvements seen after orbital decompression in patients with TED

Posted on

Patients with graves ophthalmopathy who underwent orbital decompressive surgery experience long-term improvements in overall quality of life, according to a study.

A total of 30 patients with moderate-severe graves ophthalmopathy who underwent orbital decompression surgery were retrospectively included in this study. Overall, 26 patients underwent bilateral surgery and 4 patients underwent unilateral surgery, for a total of 56 obits operated on. The majority of patients (64.3%) underwent combined bone and fat decompression surgery.

The average value of exophthalmometry before and after surgery was 24.96 (±2.68) mm and 21.8 (±2.34) mm, respectively, with an average reduction of 3.20 (±2.35) mm.

In a quality-of-life survey administered prior to surgery, the average values for visual function and appearance were of 43.3 and 44.03, respectively. After surgery, there was a mean visual function score of 76.73 and an appearance score of 73.71 (±21.89).
The authors concluded, “Orbital decompressive surgery is not only effective on GO, but also on a long-term improvement in overall well-being, self-confidence and [quality of life].

Luisa V, Riccardo T, Stefano P, et al. Effectiveness of orbital decompression for endocrine orbitopathy and impact on quality of life: A retrospective study. J Craniomaxillofac Surg. 2021;S1010-5182(21)00100-1. doi: 10.1016/j.jcms.2021.03.001. Epub ahead of print. PMID: 34218976.

Related Articles
TED biomarkers provide potential information for therapeutic targets
Apr 13, 2021
Horizon Therapeutics to resupply market with Tepezza for the treatment of thyroid eye disease (TED) beginning in April
Apr 04, 2021
Positive Phase 2a Study Results Announced for Thyroid Eye Disease Treatment
Aug 04, 2020